Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology

European Journal of Neurology

Volumn 20, Issue 10, 2013, Pages 1417-1422

  Whitwell, J L ^a   Jack, C R ^a   Parisi, J E ^a   Gunter, J L ^a   Weigand, S D ^a   Boeve, B F ^a   Ahlskog, J E ^a   Petersen, R C ^a   Dickson, D W ^b   Josephs, K A ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Midbrain; MRI; Neuropathology; Progressive supranuclear palsy; Tau

Indexed keywords

BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; AUTOPSY; BRAIN ATROPHY; CLINICAL ARTICLE; CLINICAL FEATURE; CONE BEAM COMPUTED TOMOGRAPHY; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; DISEASE ASSOCIATION; DISEASE CONTROL; FEMALE; HUMAN; HUMAN TISSUE; MALE; MESENCEPHALON; PHENOTYPE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

MIDBRAIN; MRI; NEUROPATHOLOGY; PROGRESSIVE SUPRANUCLEAR PALSY; TAU;

AGED; AGED, 80 AND OVER; ATROPHY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MESENCEPHALON; MIDDLE AGED; SUPRANUCLEAR PALSY, PROGRESSIVE; SYNDROME;

EID: 84883753333     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12212     Document Type: Article

References (24)

1. Dickson DW, Ahmed Z, Algom AA, Tsuboi Y, Josephs KA. Neuropathology of variants of progressive supranuclear palsy. Curr Opin Neurol 2010; 23: 394-400.
2. Hauw JJ, Daniel SE, Dickson D, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1994; 44: 2015-2019.
3. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996; 47: 1-9.
4. Deramecourt V, Lebert F, Debachy B, et al. Prediction of pathology in primary progressive language and speech disorders. Neurology 2010; 74: 42-49.
5. Josephs KA, Dickson DW. Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy brain bank. Mov Disord 2003; 18: 1018-1026.
6. Josephs KA, Duffy JR, Strand EA, et al. Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain 2006; 129: 1385-1398.
7. Josephs KA, Petersen RC, Knopman DS, et al. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology 2006; 66: 41-48.
8. Kertesz A, McMonagle P, Blair M, Davidson W, Munoz DG. The evolution and pathology of frontotemporal dementia. Brain 2005; 128: 1996-2005.
9. Cosottini M, Ceravolo R, Faggioni L, et al. Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging. Acta Neurol Scand 2007; 116: 37-42.
10. Groschel K, Kastrup A, Litvan I, Schulz JB. Penguins and hummingbirds: midbrain atrophy in progressive supranuclear palsy. Neurology 2006; 66: 949-950.
11. Kato N, Arai K, Hattori T. Study of the rostral midbrain atrophy in progressive supranuclear palsy. J Neurol Sci 2003; 210: 57-60.
12. Oba H, Yagishita A, Terada H, et al. New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology 2005; 64: 2050-2055.
13. Whitwell JL, Jack CR Jr, Boeve BF, et al. Imaging correlates of pathology in corticobasal syndrome. Neurology 2010; 75: 1879-1887.
14. Boeve BF, Lang AE, Litvan I. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol 2003; 54(Suppl 5): S15-S19.
15. Sled JG, Zijdenbos AP, Evans AC. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging 1998; 17: 87-97.
16. Jovicich J, Czanner S, Greve D, et al. Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data. Neuroimage 2006; 30: 436-443.
17. Whitwell JL, Xu J, Mandrekar JN, Gunter JL, Jack CR Jr, Josephs KA. Rates of brain atrophy and clinical decline over 6 and 12-month intervals in PSP: determining sample size for treatment trials. Parkinsonism Relat Disord 2012; 18: 252-256.
18. Josephs KA, Eggers SD, Jack CR Jr, Whitwell JL. Neuroanatomical correlates of the progressive supranuclear palsy corticobasal syndrome hybrid. Eur J Neurol 2012; 19: 1440-1446.
19. Josephs KA, Hodges JR, Snowden J, et al. Neuropathological background of phenotypical variability in frontotemporal dementia. Acta Neuropathol 2011; 122: 137-153.
20. Aiba I, Hashizume Y, Yoshida M, Okuda S, Murakami N, Ujihira N. Relationship between brainstem MRI and pathological findings in progressive supranuclear palsy-study in autopsy cases. J Neurol Sci 1997; 152: 210-217.
21. Massey LA, Micallef C, Paviour DC, et al. Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy. Mov Disord 2012; 27: 1754-1762.
22. Kouri N, Murray ME, Hassan A, et al. Neuropathological features of corticobasal degeneration presenting as corticobasal syndrome or Richardson syndrome. Brain 2011; 134: 3264-3275.
23. Slowinski J, Imamura A, Uitti RJ, et al. MR imaging of brainstem atrophy in progressive supranuclear palsy. J Neurol 2008; 255: 37-44.
24. Whitwell JL, Duffy JR, Strand EA, et al. Neuroimaging comparison of primary progressive apraxia of speech and progressive supranuclear palsy. Eur J Neurol 2013 20: 629-637.